Lv11
50 积分 2022-01-18 加入
The Power of Three: Retatrutide’s Role in Modern Obesity and Diabetes Therapy
2天前
已完结
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
4天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
8天前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
9天前
已完结
Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis
9天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
10天前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
15天前
已完结
What Is GLP-1 Really Doing in Obesity?
25天前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
28天前
已完结
Human Amylin: From Pathology to Physiology and Pharmacology
30天前
已完结
皖公网安备34019202002308
